Matinas BioPharma | Investor Presentation Deck | 29 slides · page 15 of 29
Mentions specific regulatory pathways (LPAD, QIDP, ODD, Fast-Track) and the ORALTO trial.
Pitch deck · roadmap · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 7/7
list 6/6 title 1/1
Components 7
bullet bullet bullet bullet bullet bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.